FR2524801B1 - Medicaments contenant un derive du psoralene - Google Patents

Medicaments contenant un derive du psoralene

Info

Publication number
FR2524801B1
FR2524801B1 FR8206262A FR8206262A FR2524801B1 FR 2524801 B1 FR2524801 B1 FR 2524801B1 FR 8206262 A FR8206262 A FR 8206262A FR 8206262 A FR8206262 A FR 8206262A FR 2524801 B1 FR2524801 B1 FR 2524801B1
Authority
FR
France
Prior art keywords
drugs containing
psoralene derivative
psoralene
derivative
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8206262A
Other languages
English (en)
Other versions
FR2524801A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR8206262A priority Critical patent/FR2524801B1/fr
Priority to BE0/210731A priority patent/BE896700A/fr
Priority to CH2751/83A priority patent/CH656801A5/fr
Priority to AU14905/83A priority patent/AU559029B2/en
Priority to CA000428960A priority patent/CA1205386A/fr
Priority to JP58097768A priority patent/JPH0653664B2/ja
Priority to GB08315070A priority patent/GB2140686B/en
Publication of FR2524801A1 publication Critical patent/FR2524801A1/fr
Application granted granted Critical
Publication of FR2524801B1 publication Critical patent/FR2524801B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR8206262A 1982-04-09 1982-04-09 Medicaments contenant un derive du psoralene Expired FR2524801B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR8206262A FR2524801B1 (fr) 1982-04-09 1982-04-09 Medicaments contenant un derive du psoralene
BE0/210731A BE896700A (fr) 1982-04-09 1983-05-09 Medicaments contenant un derive du psoralene.
CH2751/83A CH656801A5 (fr) 1982-04-09 1983-05-19 Medicaments contenant un derive du psoralene.
AU14905/83A AU559029B2 (en) 1982-04-09 1983-05-24 Drugs containing a psoralene derivative
CA000428960A CA1205386A (fr) 1982-04-09 1983-05-26 Medicaments contenant un derive psoralene
JP58097768A JPH0653664B2 (ja) 1982-04-09 1983-06-01 プソラレン誘導体含有薬剤
GB08315070A GB2140686B (en) 1982-04-09 1983-06-01 Drugs containing a psoralene derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8206262A FR2524801B1 (fr) 1982-04-09 1982-04-09 Medicaments contenant un derive du psoralene
BE0/210731A BE896700A (fr) 1982-04-09 1983-05-09 Medicaments contenant un derive du psoralene.

Publications (2)

Publication Number Publication Date
FR2524801A1 FR2524801A1 (fr) 1983-10-14
FR2524801B1 true FR2524801B1 (fr) 1985-08-30

Family

ID=36782343

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8206262A Expired FR2524801B1 (fr) 1982-04-09 1982-04-09 Medicaments contenant un derive du psoralene

Country Status (7)

Country Link
JP (1) JPH0653664B2 (fr)
AU (1) AU559029B2 (fr)
BE (1) BE896700A (fr)
CA (1) CA1205386A (fr)
CH (1) CH656801A5 (fr)
FR (1) FR2524801B1 (fr)
GB (1) GB2140686B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106365D0 (en) * 1991-03-26 1991-05-15 Bioglan Lab Ltd An emollient for use with ultraviolet light
FR2695036B1 (fr) * 1992-09-03 1994-10-28 Goupil Jean Jacques Huile contenant du 5-méthoxypsoralène à une concentration de 60 à 100 PPM et son utilisation pour le traitement du psoriasis.
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406444A1 (fr) * 1977-10-21 1979-05-18 Goupil Jean Jacques Nouveau medicament contenant un derive du psoralene
LU80347A1 (fr) * 1977-10-21 1979-03-16 Goupil J 5-methoxy-psoralene comme nouveau medicament et procede de synthese

Also Published As

Publication number Publication date
JPS59222413A (ja) 1984-12-14
GB8315070D0 (en) 1983-07-06
BE896700A (fr) 1983-09-01
AU1490583A (en) 1984-11-29
CH656801A5 (fr) 1986-07-31
GB2140686A (en) 1984-12-05
GB2140686B (en) 1986-09-17
JPH0653664B2 (ja) 1994-07-20
CA1205386A (fr) 1986-06-03
FR2524801A1 (fr) 1983-10-14
AU559029B2 (en) 1987-02-19

Similar Documents

Publication Publication Date Title
NO811931L (no) Inhaleringsanordning for pulverformige medikamenter
DK68392D0 (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
SG60887G (en) Inhalation device for administering medicaments
MC1418A1 (fr) 2,4-diamino-pyrimidines,leur preparation et medicaments contenant ces substances
FR2532848B1 (fr) Composition pharmaceutique contenant un derive polyprenylique
IL63351A0 (en) Pharmaceutical compositions containing a guanine derivative
GB2103485B (en) Liposomes containing antimonyanti-leishmanaisis drugs
DE3279436D1 (de) Corpuscules containing medicaments
FR2524314B1 (fr) Medicament a action salidiuretique, contenant des dihydropyridines
ZA81706B (en) Device for the administration of medicaments
DK521487A (da) Farmaceutisk praeparat indeholdende et resorptionsforbedrende middel
FR2524801B1 (fr) Medicaments contenant un derive du psoralene
FI831687L (fi) Farmaceutiska blandningar vilka innehaoller flere aktiva bestaondsdelar
FR2516793B1 (fr) Nouveaux medicaments immunomodulateurs contenant un derive de trithiazolepentamethylidene-cyanine
IT8321216A0 (it) Prodotti medicinali contenenti un derivato del psoralene.
AU84327S (en) a pharmaceutical dosage unit
BE890817A (fr) Medicaments pschycotropes
ES293629Y (es) Un embolo seguidor de un dispositivo distribuidor de un producto
BE887468A (fr) Compositions pharmaceutiques contenant un derive de naphtyridine
RO86393A2 (fr) Medicament a action vasculaire-trombocitaire
FI830245A0 (fi) Foerbaettringar beroerande via naesan intagbara farmaceutiska kompositioner
RO86649A2 (fr) Medicament a action antiterramateuse
RO83817A2 (fr) Produit medicamenteux a action sedative-hypnogene
FR2517201B1 (fr) Medicaments a base de di- et trisulfures
RO86248A2 (fr) Medicament antiasthmatique

Legal Events

Date Code Title Description
ST Notification of lapse
R1 Appeal
D1 Decision of the director general to report the decision of lapse
SN Distraint notified (in the national patent register)
ST Notification of lapse